| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/10/2007 | EP1741445A2 Combinations comprising dipeptidylpeptidase-IV inhibitors and antidiabetic agents |
| 01/10/2007 | EP1741441A1 Bone densifying agent characterized by use of cathepsin k inhibitor with pth |
| 01/10/2007 | EP1741440A1 Use of BPI protein for the treatment of disorders of the metabolism and cardiovascular disorders |
| 01/10/2007 | EP1741435A1 Oral modified-release lozenges and their preparation method |
| 01/10/2007 | EP1741433A1 Pharmaceutical composition comprising an androgen |
| 01/10/2007 | EP1741431A1 The combination for treating hyperlipemia |
| 01/10/2007 | EP1741428A2 Cell adhesion inhibitors |
| 01/10/2007 | EP1741427A1 Pharmaceutical composition comprising simvastatin and ezetimibe |
| 01/10/2007 | EP1740589A1 Novel 2-amino-imidazo[4,5-d]pyridazin-4-ones and 2-amino-imidazo[4,5-c]pyridin-4-ones, production and use thereof as medicaments |
| 01/10/2007 | EP1740583A1 Oxadiazolone derivatives as ppar delta agonists |
| 01/10/2007 | EP1740572A1 Novel alkyne compounds with an mch-antagonistic action and medicaments containing said compounds |
| 01/10/2007 | EP1740568A2 Benzofuran and benzothiophene derivatives useful for the treatment of cardiovascular disease. |
| 01/10/2007 | EP1740560A1 Tri(cyclo) substituted amide compounds |
| 01/10/2007 | EP1740531A1 Indene derivatives and process for the preparation thereof |
| 01/10/2007 | EP1689757A4 Heterocyclic boronic acid compounds |
| 01/10/2007 | EP1521583B1 7,8,9,10-tetrahydro-6h-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2h-pyrrolo (2,1-b)-quinazolinone derivatives |
| 01/10/2007 | EP1418915B1 Neuroprotective drug |
| 01/10/2007 | EP1417227B1 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/10/2007 | EP1416885B1 Devices for delivery of therapeutic agents with variable release profile |
| 01/10/2007 | EP1414440B1 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 01/10/2007 | EP1232180B1 Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues |
| 01/10/2007 | EP1194147B1 Arylthiazolidinedione and aryloxazolidinedione derivatives |
| 01/10/2007 | EP1087946B1 Aryl alkanoylpyridazines |
| 01/10/2007 | EP1035856B1 Isolated dna encoding human h3 histamine receptor |
| 01/10/2007 | EP0983084B1 Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders |
| 01/10/2007 | CN1894256A Method for preparing spironolactone compounds |
| 01/10/2007 | CN1894195A Ether compounds and compositions for cholesterol management and related uses |
| 01/10/2007 | CN1893980A Novel GLP-1 analogues linked to albumin-like agents |
| 01/10/2007 | CN1893965A Synergistic composition for treating hyperlipemia |
| 01/10/2007 | CN1893949A Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 01/10/2007 | CN1893946A Use of a pyrazole derivative for preparing medicaments for the prevention and the treatment of dyslipidemia and illnesses associated with dyslipidemia and/or obesity |
| 01/10/2007 | CN1893837A Serum remnant-like lipoprotein concentration regulator |
| 01/10/2007 | CN1891716A No mitogen activity anti CD3 small molecular antibody designing method |
| 01/10/2007 | CN1891704A Dipetidase tetrainhibitor, and its preparing method and use |
| 01/10/2007 | CN1891297A Medicinal composition containing angiotensin II receptor agonist and fibric acid compound |
| 01/10/2007 | CN1891296A Medicinal composition containing calcium agonist and phenoxy acid compound |
| 01/10/2007 | CN1891294A Pharmaceutical use of recombinant staphylokinase for treating high viscosity blood disease |
| 01/10/2007 | CN1891253A Effervescent tablet of straworm fruit bacteria sugar |
| 01/10/2007 | CN1891244A Composition for treating mammal hyperlipemia |
| 01/10/2007 | CN1891242A Production process for removing polycyclic aromatic hydrocarbons from ginkgo leaf extract |
| 01/10/2007 | CN1891238A Method for preparing nutrient liquid containing nucleic acid and nucleic acid raw material using biological cell |
| 01/10/2007 | CN1891233A Peptide nutrient liquid |
| 01/10/2007 | CN1891229A Medicinal composition for preventing or treating metabolic syndrome |
| 01/10/2007 | CN1891220A 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors |
| 01/10/2007 | CN1891213A Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline delivery compositions |
| 01/10/2007 | CN1891211A Method for preparing curcumin lyophilized liposome |
| 01/10/2007 | CN1294131C Pyrimidine compound |
| 01/10/2007 | CN1294117C Amidino compound and salts thereof useful as nitric oxide synahase inhibitors |
| 01/10/2007 | CN1293916C Stable insulin formulations |
| 01/10/2007 | CN1293882C Compound phytosterol with serum cholesterol-reducing action and preparing process thereof |
| 01/10/2007 | CN1293877C Neurotrophic tacrolimus analogs |
| 01/10/2007 | CN1293874C Traditional Chinese medicine Monascus purpureus went using Lovastatin salt as main active component and its preparation component |
| 01/09/2007 | US7161035 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same |
| 01/09/2007 | US7161012 Processes for preparing amorphous atorvastatin hemi-calcium |
| 01/09/2007 | US7160922 Biphenyl-4-carboxylic acid-(6-(1-((4-fluorobenzyl)methylamino)ethylideneamino)-2-hydroxyindan-1-yl)amide; cognitive activators, attention deficit/hyperactivity disorder, obesity, Alzheimer's disease, psychoses, schizophrenia; hypotensive agents for glaucoma |
| 01/09/2007 | US7160911 Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals |
| 01/09/2007 | US7160909 Cyclopenta[b]indole derivatives as sPLA2 inhibitors |
| 01/09/2007 | US7160892 Pyrimidone compounds and pharmaceutical compositions containing the same |
| 01/09/2007 | US7160889 Quinazoline compounds |
| 01/09/2007 | US7160883 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 01/09/2007 | US7160879 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1H-benzoimidazole analogues |
| 01/09/2007 | US7160877 Aliphatic nitrogen-containing 5-membered ring compound |
| 01/09/2007 | US7160874 Phenylalanine derivatives |
| 01/09/2007 | US7160862 A mixture of polypeptides, as calcium binding protein for reducing bone loss and reducing renal phosphate excretion; biodrug for treating bone disorders; injectable solution or dispersed in toothpaste or a mouthwash or gum patch |
| 01/09/2007 | US7160853 Peptides (such as terlipressin) for treatment of hypovolaemia/hypotension; for management of ascites in cirrhotic individuals |
| 01/09/2007 | CA2467490C Pharmaceutical compositions of 5,8,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene |
| 01/09/2007 | CA2407538C Novel bicyclic compounds |
| 01/09/2007 | CA2375372C Mutual prodrugs of amlodipine and atorvastatin |
| 01/09/2007 | CA2344248C 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 01/09/2007 | CA2340056C Pharmaceutical compositions containing lipase inhibitors |
| 01/09/2007 | CA2260145C Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1 |
| 01/09/2007 | CA2210985C Pharmaceutical composition containing fenofibrate and polyglycolized glycerides |
| 01/09/2007 | CA2180296C Treatment of arteriosclerosis and xanthoma |
| 01/09/2007 | CA2176511C Biologically active silicon compounds and their therapeutic and cosmetic applications |
| 01/09/2007 | CA2159988C Novel deoxygalactonojirimycin derivatives |
| 01/09/2007 | CA2144293C Substituted propane derivatives, a process for their preparation and the use of the compounds for treating diseases |
| 01/07/2007 | CA2551622A1 Dietary supplement for enhancing skeletal muscle mass, decreasing muscleprotein degradation, downregulation of muscle catabolism pathways, and decreasing catabolism of muscle cells |
| 01/04/2007 | WO2007002563A1 Imidazole based lxr modulators |
| 01/04/2007 | WO2007002559A1 Pyrazole based lxr modulators |
| 01/04/2007 | WO2007002057A1 Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists |
| 01/04/2007 | WO2007001975A1 Piperidine derivatives useful as histamine h3 antagonists |
| 01/04/2007 | WO2007001973A1 New use |
| 01/04/2007 | WO2007001939A1 Tetrahydro-pyranopyrazole compounds displaying cannabinoid modulating activities |
| 01/04/2007 | WO2007001080A1 Beverage/food and pharmaceutical comprising loquat leaf extract |
| 01/04/2007 | WO2007000924A1 Pharmaceutical composition comprising substance capable of inhibiting or promoting progranulin activity and screening method for substance capable of inhibiting or promoting progranulin activity |
| 01/04/2007 | WO2007000235A1 6-oxazol-4-ylmethoxy-alkoxymethyl substituted benzoic acid derivatives forming ppar ligands, methods for production and the use thereof in the form of drugs |
| 01/04/2007 | WO2007000118A1 Exendin 4 polypeptide fragments and use thereof |
| 01/04/2007 | WO2006125194A3 Piperazine derivatives and their uses as therapeutic agents |
| 01/04/2007 | WO2006106423A3 Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase |
| 01/04/2007 | WO2006068480A3 Protein hydrolysate enriched in peptides inhibiting dpp-iv and their use |
| 01/04/2007 | WO2006059106A3 Bispecific domain antibodies targeting serum albumin and glp-1 or pyy |
| 01/04/2007 | WO2006014865A3 Compositions containing policosanol and chromium and/or chromium salts and their pharmaceutical uses |
| 01/04/2007 | US20070004914 enhance humoral and cell-mediated immune responses to vaccine antigens; 2-deoxy-2-amino- beta -D-glucopyranose (glucosamine) glycosidically linked to an cyclic aminoalkyl (aglycon) group; viricide; immunostimulant; antiischemic agent |
| 01/04/2007 | US20070004791 (1 alpha ,5 alpha ,6 alpha )-N-[3-benzyl-3-azabicyclo[3.1.0]hexyl-6-(aminomethyl)-yl]-2-hydroxy-2,2-diphenyl acetamide; high affinity towards Muscarinic 3 receptors; avoiding adverse side effects; for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems |
| 01/04/2007 | US20070004780 Administering 2 to 8 mg per day of nontoxic insulin sensitiser rosiglitazone, and 500 mg or 850 mg of biguanide antihyperglycaemic agent; Type II diabetes |
| 01/04/2007 | US20070004743 Intranasal administration of mc4-r agonists |
| 01/04/2007 | US20070004721 Pteridine derivatives for the treatment of septic shock and tnf-a-related diseases |
| 01/04/2007 | US20070004718 Ion channel modulating compounds and uses thereof |
| 01/04/2007 | US20070004716 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 01/04/2007 | US20070004707 5HT2c agonists or partial agonists; e.g., 4,5,6,7,9a,10,11,12,13,13a-decahydro-9H-(1,4)diazepino-(6,7,1 -de)phenanthridine hydrochloride; schizophrenia, Parkinson's disease, psychosis associated with Lewy body disease, dementia, memory deficit; psychosis |